Open AccessEvaluation of effect of hybrid bioartificial liver using end-stage liver disease model
Author(s) -
Qing Liu,
Zhongping Duan,
Chin Chou Huang,
Chunhui Zhao
Publication year - 2004
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v10.i9.1379
Subject(s) - medicine , proinflammatory cytokine , gastroenterology , liver disease , multiple organ dysfunction syndrome , bioartificial liver device , systemic inflammatory response syndrome , model for end stage liver disease , bilirubin , prothrombin time , surgery , inflammation , hepatocyte , liver transplantation , biology , biochemistry , transplantation , in vitro , sepsis
To study the role of hybrid bioartificial liver (HBL) in clearing proinflammatory cytokines and endotoxin in patients with acute and sub-acute liver failure and the effects of HBL on systemic inflammatory syndrome (SIRS) and multiple organ dysfunction syndrome (MODS).